Characterisation of anti‐alpha toxin antibody levels and colonisation status after administration of an investigational human monoclonal antibody, MEDI4893, against Staphylococcus aureus alpha toxin

OBJECTIVES: MEDI4893 is a novel, long‐acting human monoclonal antibody targeting Staphylococcus aureus (SA) alpha toxin (AT). This report presents the results of the exploratory analyses from a randomised phase 1 dose‐escalation study in healthy human subjects receiving single intravenous MEDI4893 d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruzin, Alexey, Wu, Yuling, Yu, Li, Yu, Xiang‐Qing, Tabor, David E, Mok, Hoyin, Tkaczyk, Christine, Jensen, Kathryn, Bellamy, Terramika, Roskos, Lorin, Esser, Mark T, Jafri, Hasan S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822409/
https://www.ncbi.nlm.nih.gov/pubmed/29484186
http://dx.doi.org/10.1002/cti2.1009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822409/
https://www.ncbi.nlm.nih.gov/pubmed/29484186
http://dx.doi.org/10.1002/cti2.1009

Ejemplares similares